2632 / 2894
104. Rossaint R, Falke KJ, Lopez F, et al: Inhaled nitric
oxide for the adult respiratory distress syndrome. N
Engl J Med 328:399–405, 1993.
105. Lundin S, Mang H, Smithies M, et al: Inhalation of
nitric oxide in acute lung injury: Results of a Euro-
pean multicentre study. The European Study Group
of Inhaled Nitric Oxide. Intensive Care Med
25:911–919, 1999.
106. Lavoie A, Hall JB, Olson DM, Wylam ME: Life-
threatening effects of discontinuing inhaled nitric
oxide in severe respiratory failure. Am J Respir Crit
Care Med 153:1985–1987, 1996.
107. Dellinger RP, Zimmerman JL, Taylor RW, et al:
Effects of inhaled nitric oxide in patients with acute
respiratory distress syndrome: Results of a rando-
mized phase II trial. Inhaled Nitric Oxide in ARDS
Study Group. Crit Care Med 26:15–23, 1998.
108. Adhikari NK, Burns KE, Friedrich JO, et al: Effect of
nitric oxide on oxygenation and mortality in acute
lung injury: Systematic review and meta-analysis.
BMJ 334:779, 2007.
109. Esteban A, Anzueto A, Frutos F, et al: Characteristics
and outcomes in adult patients receiving mechani-
cal ventilation: A 28-day international study. JAMA
287:345–355, 2002.
110. Stauffer JL, Olson DE, Petty TL: Complications and
consequences of endotracheal intubation and tra-
cheotomy. A prospective study of 150 critically ill
adult patients. Am J Med 70:65–76, 1981.
111. Maziak DE, Meade MO, Todd TR: The timing of
tracheotomy: A systematic review. Chest 114:605–
609, 1998.
112. Rumbak MJ, Newton M, Truncale T, et al: A prospec-
tive, randomized, study comparing early percuta-
neous dilational tracheotomy to prolonged
translaryngeal intubation (delayed tracheotomy) in
critically ill medical patients. Crit Care Med
32:1689–1694, 2004.
113. Rodriguez JL, Steinberg SM, Luchetti FA, et al: Early
tracheostomy for primary airway management in
the surgical critical care setting. Surgery 108:655–
659, 1990.
114. Griffiths J, Barber VS, Morgan L, Young JD: Syste-
matic review and meta-analysis of studies of the
timing of tracheostomy in adult patients under-
going artificial ventilation. BMJ 330:1243, 2005.
115. Delaney A, Bagshaw SM, Nalos M: Percutaneous
dilatational tracheostomy versus surgical tracheos-
tomy in critically ill patients: A systematic review
and meta-analysis. Crit Care 10:R55, 2006.
116. Higgins KM, Punthakee X: Meta-analysis compari-
son of open versus percutaneous tracheostomy.
Laryngoscope 117:447–454, 2007.
117. Connors AF Jr, Speroff T, Dawson NV, et al: The
effectiveness of right heart catheterization in the
initial care of critically ill patients. SUPPORT Inves-
tigators. JAMA 276:889–897, 1996.
118. Richard C, Warszawski J, Anguel N, et al: Early use
of the pulmonary artery catheter and outcomes in
patients with shock and acute respiratory distress
syndrome: A randomized controlled trial. JAMA
290:2713–2720, 2003.
119. Wheeler AP, Bernard GR, Thompson BT, et al: Pul-
monary-artery versus central venous catheter to
guide treatment of acute lung injury. N Engl J Med
354:2213–2224, 2006.
120. Wiener RS, Welch HG: Trends in the use of the
pulmonary artery catheter in the United States,
1993-2004. JAMA 298:423–429, 2007.
121. Antonelli M, Levy M, Andrews PJ, et al: Hemodyna-
mic monitoring in shock and implications for
management. International Consensus Conference,
Paris, France, 27-28 April 2006. Intensive Care Med
33:575–590, 2007.
122. Wiedemann HP, Wheeler AP, Bernard GR, et al:
Comparison of two fluid-management strategies in
acute lung injury. N Engl J Med 354:2564–2575,
2006.
123. Rivers E, Nguyen B, Havstad S, et al: Early goal-
directed therapy in the treatment of severe sepsis and
septic shock. N Engl J Med 345:1368–1377, 2001.
124. Trey C, Davidson CS: The management of fulminant
hepatic failure. Prog Liver Dis 3:282–298, 1970.
125. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N:
Fulminant hepatic failure: Summary of a workshop.
Hepatology 21:240–252, 1995.
126. Schiodt FV, Atillasoy E, Shakil AO, et al: Etiology and
outcome for 295 patients with acute liver failure in
the United States. Liver Transpl Surg 5:29–34, 1999.
127. Ostapowicz G, Fontana RJ, Schiodt FV, et al: Results
of a prospective study of acute liver failure at 17
tertiary care centers in the United States. Ann Intern
Med 137:947–954, 2002.
128. Farmer DG, Anselmo DM, Ghobrial RM, et al: Liver
transplantation for fulminant hepatic failure: Expe-
rience with more than 200 patients over a 17-year
period. Ann Surg 237:666–675, discussion 675-676,
2003.
129. Bernal W, Wendon J: Liver transplantation in adults
with acute liver failure. J Hepatol 40:192–197,
2004.
130. Wiesner RH: MELD/PELD and the allocation of
deceased donor livers for status 1 recipients with
acute fulminant hepatic failure, primary non-
function, hepatic artery thrombosis, and acute
Wilson’s disease. Liver Transpl 10:S17–S22, 2004.
131. Bernal W, Donaldson N, Wyncoll D, Wendon J:
Blood lactate as an early predictor of outcome in
paracetamol-induced acute liver failure: A cohort
study. Lancet 359:558–563, 2002.
132. Schmidt LE, Dalhoff K: Serum phosphate is an early
predictor of outcome in severe acetaminophen-in-
duced hepatotoxicity. Hepatology 36:659–665,
2002.
133. Cordoba J, Gottstein J, Blei AT: Chronic hyponatre-
mia exacerbates ammonia-induced brain edema in
rats after portacaval anastomosis. J Hepatol 29:589–
594, 1998.
134. Davenport A: Haemofiltration in patients with ful-
minant hepatic failure. Lancet 338:1604, 1991.
135. Rolando N, Gimson A, Wade J, et al: Prospective
controlled trial of selective parenteral and enteral
antimicrobial regimen in fulminant liver failure.
Hepatology 17:196–201, 1993.
136. Shami VM, Caldwell SH, Hespenheide EE, et al:
Recombinant activated factor VII for coagulopathy
in fulminant hepatic failure compared with conven-
tional therapy. Liver Transpl 9:138–143, 2003.
137. Vaquero J, Fontana RJ, Larson AM, et al: Complica-
tions and use of intracranial pressure monitoring in
patients with acute liver failure and severe encepha-
lopathy. Liver Transpl 11:1581–1589, 2005.
138. Stravitz RT, Kramer AH, Davern T, et al: Intensive
care of patients with acute liver failure: Recommen-
dations of the U.S. Acute Liver Failure Study Group.
Crit Care Med 35:2498–2508, 2007.
139. Sen S, Williams R: New liver support devices in
acute liver failure: A critical evaluation. Semin Liver
Dis 23:283–294, 2003.
140. Demetriou AA, Brown RS Jr, Busuttil RW, et al: Pros-
pective, randomized, multicenter, controlled trial of
a bioartificial liver in treating acute liver failure. Ann
Surg 239:660–667, discussion 667-670, 2004.
141. Sen S, Davies NA, Mookerjee RP, et al: Pathophysio-
logical effects of albumin dialysis in acute-on-chro-
nic liver failure: A randomized controlled study.
Liver Transpl 10:1109–1119, 2004.
142. Kjaergard LL, Liu J, Als-Nielsen B, Gluud C: Artifi-
cial and bioartificial support systems for acute and
acute-on-chronic liver failure: A systematic review.
JAMA 289:217–222, 2003.
143. Chertow GM, Lazarus JM, Christiansen CL, et al:
Preoperative renal risk stratification. Circulation
95:878–884, 1997.
144. Vivino G, Antonelli M, Moro ML, et al: Risk factors
for acute renal failure in trauma patients. Intensive
Care Med 24:808–814, 1998.
145. Schiffl H, Lang SM, Fischer R: Daily hemodialysis
and the outcome of acute renal failure. N Engl J Med
346:305–310, 2002.
146. Kellum JA, Levin N, Bouman C, Lameire N: Deve-
loping a consensus classification system for acute
renal failure. Curr Opin Crit Care 8:509–514, 2002.
147. Hoste EA, Kellum JA: Acute kidney injury: Epide-
miology and diagnostic criteria. Curr Opin Crit
Care 12:531–537, 2006.
148. Ronco C, Bellomo R, Homel P, et al: Effects of diffe-
rent doses in continuous veno-venous haemofiltra-
tion on outcomes of acute renal failure: A
prospective randomised trial. Lancet 356:26–30,
2000.
149. Bouman CS, Oudemans-Van Straaten HM, Tijssen
JG, et al: Effects of early high-volume continuous
venovenous hemofiltration on survival and reco-
very of renal function in intensive care patients with
acute renal failure: A prospective, randomized trial.
Crit Care Med 30:2205–2211, 2002.
150. Joannidis M: Acute kidney injury in septic
shock—do not under-treat!. Intensive Care Med
32:18–20, 2006.
151. Piccinni P, Dan M, Barbacini S, et al: Early isovolae-
mic haemofiltration in oliguric patients with septic
shock. Intensive Care Med 32:80–86, 2006.
152. Kumar VA, Yeun JY, Depner TA, Don BR: Exten-
ded daily dialysis vs. continuous hemodialysis for
ICU patients with acute renal failure: A two-year
single center report. Int J Artif Organs 27:371–379,
2004.
153. Vinsonneau C, Camus C, Combes A, et al: Conti-
nuous venovenous haemodiafiltration versus inter-
mittent haemodialysis for acute renal failure in
patients withmultiple-organ dysfunction syndrome:
A multicentre randomised trial. Lancet 368:379–
385, 2006.
154. Legras A, Malvy D, Quinioux AI, et al: Nosocomial
infections: Prospective survey of incidence in five
French intensive care units. Intensive Care Med
24:1040–1046, 1998.
155. Jarvis WR, Edwards JR, Culver DH, et al: Nosoco-
mial infection rates in adult and pediatric intensive
care units in the United States. National Nosocomial
Infections Surveillance System. Am J Med 91:185S–
191S, 1991.
156. Richards MJ, Edwards JR, Culver DH, Gaynes RP:
Nosocomial infections in medical intensive care
units in the United States. National Nosocomial
Infections Surveillance System. Crit Care Med
27:887–892, 1999.
157. Misset B, Timsit JF, Dumay MF, et al: A continuous
quality-improvement program reduces nosocomial
infection rates in the ICU. Intensive Care Med
30:395–400, 2004.
158. Zack JE, Garrison T, Trovillion E, et al: Effect of an
education program aimed at reducing the occu-
rrence of ventilator-associated pneumonia. Crit
Care Med 30:2407–2412, 2002.
159. Pingleton SK, Fagon JY, Leeper KV Jr: Patient selec-
tion for clinical investigation of ventilator-associa-
ted pneumonia. Criteria for evaluating diagnostic
techniques. Chest 102:553S–556S, 1992.
160. George DL, Falk PS, Wunderink RG, et al: Epide-
miology of ventilator-acquired pneumonia based
on protected bronchoscopic sampling. Am J Respir
Crit Care Med 158:1839–1847, 1998.
161. Fagon JY, Chastre J, Hance AJ, et al: Nosocomial
pneumonia in ventilated patients: A cohort study
evaluating attributable mortality and hospital stay.
Am J Med 94:281–288, 1993.
162. Heyland DK, Cook DJ, Griffith L, et al: The attribu-
table morbidity and mortality of ventilator-associa-
ted pneumonia in the critically ill patient. The
Canadian Critical Trials Group. Am J Respir Crit
Care Med 159:1249–1256, 1999.
163. Ibrahim EH, Tracy L, Hill C, et al: The occurrence
of ventilator-associated pneumonia in a community
hospital: Risk factors and clinical outcomes. Chest
120:555–561, 2001.
164. Chastre J, Fagon JY: Invasive diagnostic testing
should be routinely used to manage ventilated
patients with suspected pneumonia. Am J Respir
Crit Care Med 150:570–574, 1994.
165. Baker AM, Meredith JW, Haponik EF: Pneumonia
in intubated trauma patients. Microbiology and
outcomes. Am J Respir Crit Care Med 153:343–349,
1996.
166. Craven DE, Steger KA: Nosocomial pneumonia in
mechanically ventilated adult patients: Epidemio-
logy and prevention in 1996. Semin Respir Infect
11:32–53, 1996.
2632
Cuidados críticos
VII